---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-177290"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:10:23.203418+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools receives Nasdaq bid price deficiency notice; 180-day cure period through Oct 19, 2026

## Summary
- Notice on April 20, 2026: common stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until October 19, 2026) to regain compliance by maintaining $1.00 closing bid for 10 consecutive days.
- If eligible, company may transfer to Nasdaq Capital Market for an additional 180-day cure period, subject to fees and conditions.
- Trading under ticker LAB continues uninterrupted; no effect on business operations or SEC reporting.
- Company intends to cure, but no assurance of regaining compliance or extension.

## SEC filing metadata
- accession: 0001193125-26-177290
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000119312526177290/0001193125-26-177290-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000119312526177290/lab-20250913.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-177290
- JSON: https://secwatch.observer/filing/0001193125-26-177290.json
- Plain text: https://secwatch.observer/filing/0001193125-26-177290.txt

## Source-grounded claims
- claim_id: fc62c6637570bd2ac86c9e4e1acaefb63879faae
  claim: STANDARD BIOTOOLS INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  evidence_excerpt: April 20, 2026, Standard BioTools Inc. (NASDAQ: LAB) (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (the “Nasdaq”) in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312526177290/0001193125-26-177290-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.